Please login to the form below

Ashfield publishes white paper on sales outsourcing as a change partner

Ashfield, assisted by Dr Beth Rogers, has investigated the future of outsourcing with 16 senior sales and buying professionals from pharmaceutical companies across Europe. The insights are shared in our whitepaper, ‘Flex in a time of flux: Sales outsourcing as a change partner in the pharmaceutical sector.’



Pharmaceutical companies are facing unprecedented change. Product portfolios are migrating from mass market solutions to highly specialised therapies, relevant to relatively small patient populations. Reimbursement is becoming increasingly complex and successful commercialisation means targeting multiple stakeholders before a prescription is even written.

In response, the pharma industry is exploring new sales and marketing models, evolving its core strategies to meet these modern, multifaceted challenges.

Historically, contract sales organisations (CSOs) have provided a flexible, cost-effective means for the pharma industry to adjust the implementation of its sales strategy. However, given the current state of flux, just how relevant can CSOs be in helping pharma manage such major change?

In July 2017, Ashfield conducted an online Advisory Board discussion to investigate the issue. The participants included 14 senior sales and buying professionals from pharmaceutical companies across Europe. Together, they debated the advantages, challenges and possible future use of CSOs. Five follow-up interviews – including two with additional clients – and an Ashfield idea generation session were also undertaken.

Dr Beth Rogers, author of Rethinking Sales Management and several articles and papers on the outsourcing of sales functions, assisted Ashfield in moderating the advisory board, conducting the follow-up interviews and writing the white paper.

This white paper considers how the relationship between pharmaceutical companies and CSOs has developed and the characteristics that pharmaceutical companies today look for in a strategic CSO partner. It also explores how that relationship is expected to change in the next five years, and how services and outsourcing models will evolve.

Click here to download the white paper!

2nd November 2017

Share

Tags

Company Details

Ashfield

Contact Website

Address:
Ashfield House
Resolution Road
Ashby de la Zouch
Leicestershire
LE65 1HW
UK

Latest content on this profile

‘Delivering healthcare events with certainty and impact’
Ashfield Meetings & Events launches new website Ashfieldmeetings.com
Ashfield
The Ashfield Solution - Accelerate product uptake and maximize ROI
A pioneering multichannel optimization model powered by advanced analytics with the ability to flex resources based on real time results.
Ashfield
Patient Engagement and Experience Conference, 16-17 May
Ashfield and S3 Connected Health, Silver Sponsors at the 3rd Annual Patient Engagement and Experience Conference in Amsterdam on 16-17 May, will be speaking on how digitally enhanced Patient Support Programmes can extend the continuity and relevance of care into patients’ everyday lives.
Ashfield
Ashfield will be exhibiting at ISMPP US
On 30 April - 2 May 2018, Ashfield Healthcare Communications will be exhibiting at the 14th Annual Meeting of ISMPP at the Gaylord National Resort & Convention Center, National Harbor, MD.
Ashfield
Putting the patient first
You’ve invested millions in the development of your new drug or therapy and have successfully completed clinical trials - now you are ready to launch. Data has been collected, efficacy is understood and side effects are recorded. But an important question remains: is your target patient population prepared?
Ashfield
Ashfield joins the eyeforpharma webinar: The PSP Masterclass
Nagore Fernandez, Ashfield’s Head of Patient Services for EUCAN and Anna Baker, a Consultant in Health Psychology working closely with Ashfield, are joining an eyeforpharma panel debate: 'How Health Psychology drives winning Patient Support Programmes'. The webinar will take place Thursday 26th April at 9am New York, 2pm UK and 3pm Paris time.
Ashfield